Moreover, loss of HER1 and 2 are associated with reducing cellular proliferation and invasion of HER2-positive human breast cancer [42], [43]; this is in concordance with our data of PAMAM-induced decreased cell proliferation and colony formation. Here, EGFR is linked to breast carcinoma.